Nano-hydroxyapatite promotes cell apoptosis by co-activating endoplasmic reticulum stress and mitochondria damage to inhibit glioma growth

  • 0National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, P. R. China.

|

|

Summary

This summary is machine-generated.

Nano-hydroxyapatite (n-HA) triggers cancer cell death by inducing endoplasmic reticulum (ER) stress and mitochondrial damage. This study clarifies n-HA

Area Of Science

  • Biomaterials Science
  • Cancer Biology
  • Cellular and Molecular Mechanisms

Background

  • Nano-hydroxyapatite (n-HA) shows anti-tumor effects, but its precise mechanisms are not fully understood.
  • Endoplasmic reticulum (ER) and mitochondria are crucial for calcium (Ca2+) homeostasis and cellular stress responses.
  • The interplay between ER and mitochondria in Ca2+ regulation is vital for preventing cellular damage.

Purpose Of The Study

  • To investigate the anti-tumor effectiveness of needle-like n-HA.
  • To elucidate the underlying cellular and molecular mechanisms of n-HA's anti-glioma effects.
  • To explore the role of ER-mitochondria interplay in n-HA-induced cancer cell apoptosis.

Main Methods

  • Fabrication of needle-like nano-hydroxyapatite (n-HA).
  • In vitro studies on glioma cell growth and invasion.
  • Analysis of ER stress biomarkers, intracellular reactive oxygen species, and mitochondrial membrane potential.
  • In vivo experiments to assess tumor growth inhibition.

Main Results

  • n-HA significantly reduced glioma cell growth and invasion in vitro.
  • n-HA treatment upregulated ER stress biomarkers (GRP78, p-IRE1, p-PERK, PERK, ATF6) and activated CHOP, inducing apoptosis.
  • n-HA caused increased reactive oxygen species, mitochondrial membrane depolarization, and downstream apoptotic signaling, indicating Ca2+ overload and mitochondrial damage.
  • In vivo studies confirmed n-HA's ability to induce ER stress and mitochondrial damage, effectively restraining glioma tumor growth.

Conclusions

  • n-HA induces cancer cell apoptosis by co-activating ER stress and mitochondrial damage.
  • The findings offer new insights into ER-mitochondria targeted anti-tumor therapies.
  • n-HA presents a promising therapeutic agent for glioma treatment.